Skip to main content
Log in

Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate survival and distant tumor growth after radiofrequency ablation (RFA) and local OK-432 injection at a single tumor site in a rabbit model with intra- and extrahepatic VX2 tumors and to examine the effect of this combination therapy, which we termed immuno-radiofrequency ablation (immunoRFA), on systemic antitumor immunity in a rechallenge test.

Methods

Our institutional animal care committee approved all experiments. VX2 tumors were implanted to three sites: two in the liver and one in the left ear. Rabbits were randomized into four groups of seven to receive control, RFA alone, OK-432 alone, and immunoRFA treatments at a single liver tumor at 1 week after implantation. Untreated liver and ear tumor volumes were measured after the treatment. As the rechallenge test, tumors were reimplanted into the right ear of rabbits, which survived the 35 weeks and were followed up without additional treatment. Statistical significance was examined by log-rank test for survival and Student’s t test for tumor volume.

Results

Survival was significantly prolonged in the immunoRFA group compared to the other three groups (P < 0.05). Untreated liver and ear tumor sizes became significantly smaller after immunoRFA compared to controls (P < 0.05). In the rechallenge test, the reimplanted tumors regressed without further therapy compared to the ear tumors of the control group (P < 0.05).

Conclusion

ImmunoRFA led to improved survival and suppression of distant untreated tumor growth. Decreases in size of the distant untreated tumors and reimplanted tumors suggested that systemic antitumor immunity was enhanced by immunoRFA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209

    Article  PubMed  Google Scholar 

  2. Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206–1213

    Article  PubMed  CAS  Google Scholar 

  3. McWilliams JP, Yamamoto S, Raman SS et al (2010) Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol 21:S204–S213

    Article  PubMed  Google Scholar 

  4. Dromi SA, Walsh MP, Herby S et al (2009) Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 251:58–66

    Article  PubMed  Google Scholar 

  5. Hansler J, Wissniowski TT, Schuppan D et al (2006) Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 12:3716–3721

    PubMed  Google Scholar 

  6. Zerbini A, Pilli M, Penna A et al (2006) Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66:1139–1146

    Article  PubMed  CAS  Google Scholar 

  7. Baran J, Baj-Krzyworzeka M, Weglarczyk K et al (2004) Modulation of monocyte-tumour cell interactions by Mycobacterium vaccae. Cancer Immunol Immunother 53:1127–1134

    Article  PubMed  CAS  Google Scholar 

  8. Yamamoto A, Chervoneva I, Sullivan KL et al (2009) High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology 252:290–298

    Article  PubMed  Google Scholar 

  9. Nakamoto Y, Mizukoshi E, Kitahara M et al (2011) Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization. Clin Exp Immunol 163:165–177

    Article  PubMed  CAS  Google Scholar 

  10. Okamoto H, Shoin S, Koshimura S et al (1967) Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11:323–326

    PubMed  CAS  Google Scholar 

  11. Homma S, Sagawa Y, Komita H et al (2007) Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation. Cancer Immunol Immunother 56:1265–1274

    Article  PubMed  Google Scholar 

  12. Koido S, Hara E, Homma S et al (2007) Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunol 178:613–622

    PubMed  CAS  Google Scholar 

  13. Hovden AO, Karlesen M, Jonsson R et al (2011) Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol 12:2

    Article  PubMed  CAS  Google Scholar 

  14. Nakahara S, Tsunoda T, Baba T et al (2003) Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide. Cancer Res 63:4112–4118

    PubMed  CAS  Google Scholar 

  15. Acevedo JL, Shah RK, Brietzke SE (2008) Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 138:418–424

    Article  PubMed  Google Scholar 

  16. Shimizu J, Hayashi Y, Oda M et al (1994) Treatment of postoperative chylothorax by pleurodesis with the streptococcal preparation OK-432. Thorac Cardiovasc Surg 42:233–236

    Article  PubMed  CAS  Google Scholar 

  17. Olsnes C, Stavang H, Brokstad K et al (2009) Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation. BMC Immunol 10:6

    Article  PubMed  Google Scholar 

  18. Virmani S, Harris KR, Szolc-Kowalska B et al (2008) Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol 19:931–936

    Article  PubMed  Google Scholar 

  19. MacMahon PJ, Kennedy AM, Murphy DT et al (2009) Modified prostate volume algorithm improves transrectal US volume estimation in men presenting for prostate brachytherapy. Radiology 250:273–280

    Article  PubMed  Google Scholar 

  20. Kuszyk BS, Boitnott JK, Choti MA et al (2000) Local tumor recurrence following hepatic cryoablation: radiologic–histopathologic correlation in a rabbit model. Radiology 217:477–486

    PubMed  CAS  Google Scholar 

  21. Okuma T, Matsuoka T, Okamura T et al (2006) 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351–1358

    PubMed  Google Scholar 

  22. Hansler J, Neureiter D, Wasserburger M et al (2004) Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology 230:169–174

    Article  PubMed  Google Scholar 

  23. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  PubMed  CAS  Google Scholar 

  24. Jochems C, Schlom J (2011) Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 236:567–579

    Article  CAS  Google Scholar 

  25. Wissniowski TT, Hansler J, Neureiter D et al (2003) Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 63:6496–6500

    PubMed  CAS  Google Scholar 

  26. Rao P, Escudier B, de Baere T (2011) Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Interv Radiol 34:424–430

    Article  Google Scholar 

  27. Seki T, Wakabayashi M, Nakagawa T et al (1994) Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74:817–825

    Article  PubMed  CAS  Google Scholar 

  28. Kallio R, Sequeiros R, Surcel HM et al (2006) Early cytokine responses after percutaneous magnetic resonance imaging guided laser thermoablation of malignant liver tumors. Cytokine 34:278–283

    Article  PubMed  CAS  Google Scholar 

  29. den Brok MH, Sutmuller RP, van der Voort R et al (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64:4024–4029

    Article  Google Scholar 

  30. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671):86–89

    Article  PubMed  CAS  Google Scholar 

  31. Shi H, Cao T, Connolly JE et al (2006) Hyperthermia enhances CTL cross-priming. J Immunol 176:2134–2141

    PubMed  CAS  Google Scholar 

  32. Callahan MK, Wohlfert EA, Menoret A, Srivastava PK (2006) Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes. J Immunol 177:8393–8399

    PubMed  CAS  Google Scholar 

  33. Zhang X, Gordon JR, Xiang J (2002) Advances in dendritic cell-based vaccine of cancer. Cancer Biother Radiopharm 17:601–619

    Article  PubMed  CAS  Google Scholar 

  34. Crispe IN, Giannandrea M, Klein I et al (2006) Cellular and molecular mechanisms of liver tolerance. Immunol Rev 213:101–118

    Article  PubMed  Google Scholar 

  35. Haen SP, Gouttefangeas C, Schmidt D et al (2011) Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. Cell Stress Chaperones 16:495–504

    Article  PubMed  CAS  Google Scholar 

  36. Ito A, Shinkai M, Honda H et al (2001) Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 50:515–522

    Article  PubMed  CAS  Google Scholar 

  37. Chen W, Syldath U, Bellmann K et al (1999) Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 162:3212–3219

    PubMed  CAS  Google Scholar 

  38. Singh-Jasuja H, Scherer HU, Hilf N et al (2000) The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30:2211–2215

    PubMed  CAS  Google Scholar 

  39. Nakamoto Y, Mizukoshi E, Tsuji H et al (2007) Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety. Clin Exp Immunol 147:296–305

    Article  PubMed  CAS  Google Scholar 

  40. Johnson EE, Yamane BH, Buhtoiarov IN et al (2009) Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res 15:4875–4884

    Article  PubMed  CAS  Google Scholar 

  41. Saito K, Araki K, Reddy N et al (2011) Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model. Head Neck 33:359–367

    PubMed  Google Scholar 

  42. Ogita K, Taguchi T, Suita S (2006) Experimental study concerning safety dosage of OK-432 for intrauterine treatment. Asian J Surg 29:202–206

    Article  PubMed  Google Scholar 

  43. Jie KG, Jiang H, Sun L et al (2007) The pilot study of anti-tumor effects versus immunosuppression of Staphylococcal enterotoxin C. Cancer Biol Ther 6:1584–1591

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Grant-in-aid for Scientific Research (KAKENHI) 23791437 of Japan. We thank Prof. Sato’s laboratory at Thomas Jefferson University for providing a valuable insight that led to the idea of combining immunotherapy and interventional therapy.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ken Kageyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kageyama, K., Yamamoto, A., Okuma, T. et al. Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors. Cardiovasc Intervent Radiol 36, 1383–1392 (2013). https://doi.org/10.1007/s00270-013-0650-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-013-0650-y

Keywords

Navigation